̽»¨¾«Ñ¡

Team Stem Cell and Organoid models in health and disease: Nuclear receptor signaling mechanisms

We investigate how liver X receptors (LXRs) and estrogen receptor beta (ERβ) regulate immune responses, cholesterol metabolism, and cellular differentiation, with a particular focus on their roles in neurodegeneration. Using stem cell biology and 3D organoid technologies, we replicate human physiology to explore disease mechanisms in a human-relevant context. Our work also examines lipid metabolism and nuclear receptor signaling in the progression of cancer and inflammatory conditions.

A process overview of Stem Cell and Organoid models in Neurodegeneration and Neurotropic Infections.
Stem Cell and Organoid models in Neurodegeneration and Neurotropic Infections. Photo: Biorender

Our research integrates nuclear receptor biology with cutting-edge stem cell technologies to uncover disease mechanisms and develop innovative therapeutic strategies. A central focus is the application of organoid and organ-on-chip systems derived from stem cells to study nuclear receptor signaling in neurodegenerative diseases, cancer, and other conditions. These animal-free, human-relevant models allow us to dissect complex interactions and uncover developmental mechanisms underlying genetic disorders. By leveraging advanced tools such as gene editing, high-throughput omics, and multi-modal imaging, we aim to identify novel therapeutic targets and validate effective interventions. 

Current projects

  • VINNOVA
  • Influence of Estrogen on Brain Insulin Resistance in Alzheimer’s disease
  • LXR-ER crosstalk in neurodevelopment, neuroinflammation and neurodegenerative disorders
  • Decoding Cancer’s Lipid Secrets with Oxysterols, LXRs, and Patient-Derived Organoids
  • Complex in vitro models of reproductive system

Main collaborators

LXR and ER in health and disease

Jan-Ã…ke Gustafsson, Prof., Karolinska Institute, Sweden and University of Houston, USA

Margaret Warner, Prof., University of Houston, USA

Organoid models in fertility preservation for young cancer survivors

Kenny Rodriguez-Wallberg, Prof., Karolinska University Hospital and ONKPAT, Karolinska Institute, Sweden

Super resolution and label-free imaging of 3D in vitro models

Balpreet S Ahluwalia, Prof., Arctic University of Tromso (UiT), Norway and Karolinska Institute, Sweden

PET tracer characterization in AD/PD brain organoids

Amit Kumar, PhD, Karolinska Institute, Sweden

Neurotoxicity in brain development

Kristina Pilipovic, Prof., Faculty of Medicine, University of Rijeka, Croatia

Selected Publications


Jiang Y, Palomares AR, Munoz P, Nalvarte I, Acharya G, Inzunza J, Varshney M, Rodriguez-Wallberg KA
Cells 2024 Nov;13(21):


Rocha FM, Roy A, Varshney M, Kumar A
Alzheimers Dement 2025 Feb;21(2):e14488


Song X, Wu W, Dai Y, Warner M, Nalvarte I, Antonson P, Varshney M, Gustafsson JÃ…
Int J Mol Sci 2023 Aug;24(15):


Inzunza J, Arias-Fuenzalida J, Segura-Aguilar J, Nalvarte I, Varshney M
Stem Cell Res 2021 Mar;51():102193


Varshney MK, Yu NY, Katayama S, Li X, Liu T, Wu WF, Töhönen V, Krjutškov K, Kere J, Fan X, Inzunza J, Gustafsson JÅ, Nalvarte I
Neuroendocrinology 2021 ;111(1-2):27-44


Varshney MK, Inzunza J, Lupu D, Ganapathy V, Antonson P, Rüegg J, Nalvarte I, Gustafsson JÅ
Proc Natl Acad Sci U S A 2017 Nov;114(48):E10428-E10437

Complete Publication List

Contact

Profile image

Mukesh Varshney

Team Leader
Department of Laboratory Medicine
Content reviewer:
12-03-2025